Effect of intra-arterial nimodipine on iatrogenic vasospasms during endovascular stroke treatment – angiographic resolution and infarct growth in follow-up imaging

Abstract Purpose The treatment of vasospasms during endovascular stroke treatment (EST) with intra-arterial nimodipine (NM) is routinely performed. However, the efficacy of resolving iatrogenic vasospasms during the angiographic intervention and the infarct development in follow-up imaging after EST...

Full description

Bibliographic Details
Main Authors: Jessica Jesser, Arne Potreck, Dominik Vollherbst, Fatih Seker, Min Chen, Silvia Schönenberger, Thuy D. Do, Martin Bendszus, Markus A. Möhlenbruch, Charlotte S. Weyland
Format: Article
Language:English
Published: BMC 2023-01-01
Series:BMC Neurology
Subjects:
Online Access:https://doi.org/10.1186/s12883-022-03045-x
_version_ 1797958589952819200
author Jessica Jesser
Arne Potreck
Dominik Vollherbst
Fatih Seker
Min Chen
Silvia Schönenberger
Thuy D. Do
Martin Bendszus
Markus A. Möhlenbruch
Charlotte S. Weyland
author_facet Jessica Jesser
Arne Potreck
Dominik Vollherbst
Fatih Seker
Min Chen
Silvia Schönenberger
Thuy D. Do
Martin Bendszus
Markus A. Möhlenbruch
Charlotte S. Weyland
author_sort Jessica Jesser
collection DOAJ
description Abstract Purpose The treatment of vasospasms during endovascular stroke treatment (EST) with intra-arterial nimodipine (NM) is routinely performed. However, the efficacy of resolving iatrogenic vasospasms during the angiographic intervention and the infarct development in follow-up imaging after EST has not been studied yet. Methods Retrospective single-center analysis of patients receiving EST for anterior circulation vessel occlusion between 01/2015 and 12/2021. The primary endpoint was ASPECTS in follow-up imaging. Secondary endpoints were the clinical outcome (combined endpoint NIHSS 24 h after EST and difference between modified Rankin Scale (mRS) before stroke and at discharge (delta mRS)) and intracranial hemorrhage (ICH) in follow-up imaging. Patients with vasospasms receiving NM (NM+) or not (NM-) were compared in univariate analysis. Results Vasospasms occurred in 79/1283 patients (6.2%), who consecutively received intra-arterial NM during EST. The targeted vasospasm angiographically resolved in 84% (66/79) under NM therapy. ASPECTS was lower in follow-up imaging after vasospasms and NM-treatment (NM – 7 (6–9), NM + 6 (4.5-8), p = 0.013) and the clinical outcome was worse (NIHSS 24 h after EST was higher in patients treated with NM (median, IQR; NM+: 14, 5–21 vs. NM-: 9, 3–18; p = 0.004), delta-mRS was higher in the NM + group (median, IQR; NM+: 3, 1–4 vs. NM-: 2, 1–2; p = 0.011)). Any ICH (NM+: 27/79, 34.2% vs. NM-: 356/1204, 29.6%; p = 0.386) and symptomatic ICH (NM+: 2/79, 2.5% vs. NM-: 21/1204, 1.7%; p = 0.609) was equally distributed between groups. Conclusion Intra-arterial nimodipine during EST resolves iatrogenic vasospasms efficiently during EST without increasing intracranial hemorrhage rates. However, patients with vasospasms and NM treatment show higher infarct growth resulting in lower ASPECTS in follow-up imaging.
first_indexed 2024-04-11T00:22:11Z
format Article
id doaj.art-abe0e7fdb09c4aa6b6a23e7446b0dc8c
institution Directory Open Access Journal
issn 1471-2377
language English
last_indexed 2024-04-11T00:22:11Z
publishDate 2023-01-01
publisher BMC
record_format Article
series BMC Neurology
spelling doaj.art-abe0e7fdb09c4aa6b6a23e7446b0dc8c2023-01-08T12:15:01ZengBMCBMC Neurology1471-23772023-01-012311810.1186/s12883-022-03045-xEffect of intra-arterial nimodipine on iatrogenic vasospasms during endovascular stroke treatment – angiographic resolution and infarct growth in follow-up imagingJessica Jesser0Arne Potreck1Dominik Vollherbst2Fatih Seker3Min Chen4Silvia Schönenberger5Thuy D. Do6Martin Bendszus7Markus A. Möhlenbruch8Charlotte S. Weyland9Department of Neuroradiology, Heidelberg University HospitalDepartment of Neuroradiology, Heidelberg University HospitalDepartment of Neuroradiology, Heidelberg University HospitalDepartment of Neuroradiology, Heidelberg University HospitalDepartment of Neurology, Heidelberg University HospitalDepartment of Neurology, Heidelberg University HospitalDepartment of Diagnostic and Interventional Radiology, Heidelberg University HospitalDepartment of Neuroradiology, Heidelberg University HospitalDepartment of Neuroradiology, Heidelberg University HospitalDepartment of Neuroradiology, Heidelberg University HospitalAbstract Purpose The treatment of vasospasms during endovascular stroke treatment (EST) with intra-arterial nimodipine (NM) is routinely performed. However, the efficacy of resolving iatrogenic vasospasms during the angiographic intervention and the infarct development in follow-up imaging after EST has not been studied yet. Methods Retrospective single-center analysis of patients receiving EST for anterior circulation vessel occlusion between 01/2015 and 12/2021. The primary endpoint was ASPECTS in follow-up imaging. Secondary endpoints were the clinical outcome (combined endpoint NIHSS 24 h after EST and difference between modified Rankin Scale (mRS) before stroke and at discharge (delta mRS)) and intracranial hemorrhage (ICH) in follow-up imaging. Patients with vasospasms receiving NM (NM+) or not (NM-) were compared in univariate analysis. Results Vasospasms occurred in 79/1283 patients (6.2%), who consecutively received intra-arterial NM during EST. The targeted vasospasm angiographically resolved in 84% (66/79) under NM therapy. ASPECTS was lower in follow-up imaging after vasospasms and NM-treatment (NM – 7 (6–9), NM + 6 (4.5-8), p = 0.013) and the clinical outcome was worse (NIHSS 24 h after EST was higher in patients treated with NM (median, IQR; NM+: 14, 5–21 vs. NM-: 9, 3–18; p = 0.004), delta-mRS was higher in the NM + group (median, IQR; NM+: 3, 1–4 vs. NM-: 2, 1–2; p = 0.011)). Any ICH (NM+: 27/79, 34.2% vs. NM-: 356/1204, 29.6%; p = 0.386) and symptomatic ICH (NM+: 2/79, 2.5% vs. NM-: 21/1204, 1.7%; p = 0.609) was equally distributed between groups. Conclusion Intra-arterial nimodipine during EST resolves iatrogenic vasospasms efficiently during EST without increasing intracranial hemorrhage rates. However, patients with vasospasms and NM treatment show higher infarct growth resulting in lower ASPECTS in follow-up imaging.https://doi.org/10.1186/s12883-022-03045-xEndovascular stroke treatmentThrombectomyVasospasmNimodipineIntracranial hemorrhageASPECTS
spellingShingle Jessica Jesser
Arne Potreck
Dominik Vollherbst
Fatih Seker
Min Chen
Silvia Schönenberger
Thuy D. Do
Martin Bendszus
Markus A. Möhlenbruch
Charlotte S. Weyland
Effect of intra-arterial nimodipine on iatrogenic vasospasms during endovascular stroke treatment – angiographic resolution and infarct growth in follow-up imaging
BMC Neurology
Endovascular stroke treatment
Thrombectomy
Vasospasm
Nimodipine
Intracranial hemorrhage
ASPECTS
title Effect of intra-arterial nimodipine on iatrogenic vasospasms during endovascular stroke treatment – angiographic resolution and infarct growth in follow-up imaging
title_full Effect of intra-arterial nimodipine on iatrogenic vasospasms during endovascular stroke treatment – angiographic resolution and infarct growth in follow-up imaging
title_fullStr Effect of intra-arterial nimodipine on iatrogenic vasospasms during endovascular stroke treatment – angiographic resolution and infarct growth in follow-up imaging
title_full_unstemmed Effect of intra-arterial nimodipine on iatrogenic vasospasms during endovascular stroke treatment – angiographic resolution and infarct growth in follow-up imaging
title_short Effect of intra-arterial nimodipine on iatrogenic vasospasms during endovascular stroke treatment – angiographic resolution and infarct growth in follow-up imaging
title_sort effect of intra arterial nimodipine on iatrogenic vasospasms during endovascular stroke treatment angiographic resolution and infarct growth in follow up imaging
topic Endovascular stroke treatment
Thrombectomy
Vasospasm
Nimodipine
Intracranial hemorrhage
ASPECTS
url https://doi.org/10.1186/s12883-022-03045-x
work_keys_str_mv AT jessicajesser effectofintraarterialnimodipineoniatrogenicvasospasmsduringendovascularstroketreatmentangiographicresolutionandinfarctgrowthinfollowupimaging
AT arnepotreck effectofintraarterialnimodipineoniatrogenicvasospasmsduringendovascularstroketreatmentangiographicresolutionandinfarctgrowthinfollowupimaging
AT dominikvollherbst effectofintraarterialnimodipineoniatrogenicvasospasmsduringendovascularstroketreatmentangiographicresolutionandinfarctgrowthinfollowupimaging
AT fatihseker effectofintraarterialnimodipineoniatrogenicvasospasmsduringendovascularstroketreatmentangiographicresolutionandinfarctgrowthinfollowupimaging
AT minchen effectofintraarterialnimodipineoniatrogenicvasospasmsduringendovascularstroketreatmentangiographicresolutionandinfarctgrowthinfollowupimaging
AT silviaschonenberger effectofintraarterialnimodipineoniatrogenicvasospasmsduringendovascularstroketreatmentangiographicresolutionandinfarctgrowthinfollowupimaging
AT thuyddo effectofintraarterialnimodipineoniatrogenicvasospasmsduringendovascularstroketreatmentangiographicresolutionandinfarctgrowthinfollowupimaging
AT martinbendszus effectofintraarterialnimodipineoniatrogenicvasospasmsduringendovascularstroketreatmentangiographicresolutionandinfarctgrowthinfollowupimaging
AT markusamohlenbruch effectofintraarterialnimodipineoniatrogenicvasospasmsduringendovascularstroketreatmentangiographicresolutionandinfarctgrowthinfollowupimaging
AT charlottesweyland effectofintraarterialnimodipineoniatrogenicvasospasmsduringendovascularstroketreatmentangiographicresolutionandinfarctgrowthinfollowupimaging